1992 Fiscal Year Final Research Report Summary
Study on pathogenesis of endometrial carcinomas based on the analysis of growth and differentiation of endometrial gland
| Project/Area Number |
03670781
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Obstetrics and gynecology
|
|---|
| Research Institution | KYOTO UNIVERSITY |
|---|
Principal Investigator |
KONISHI Ikuo Kyoto University, Faculty of Medicine Associate Professor, 医学部, 講師 (90192062)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
FUJII Shingo Shinshu University, Faculty of Medicine Professor & Chairman, 医学部, 教授 (30135579)
|
|---|
| Project Period (FY) |
1991 – 1992
|
| Keywords | endometrium / endometrial carcinoma / sex steroid receptor / c-erbB-2 protein / EGFR / p53 |
|---|
| Research Abstract |
To verify the pathogenesis of endometrial carcinomas, expression of growth and differentiation factors such as sex steroid receptors (estrogen receptor; ER, progesterone receptors; PR), peptide growth factor receptors (c-erbB-2 protein, epidermal growth factor receptor; EGFR), and antioncogene product p53, has been studied immunohistochemically in normal, hyperplastic, and carcinomatous endometra. In normal endometrial glands, ER and PR are strongly expressed in the proliferative phase, but are down- regulated during the secretory phase. In contrast, hyperplastic and carcinomatous endometria exhibit constitutive expression of ER and/or PR, which is expressed in 70% cases of endometrial carcinomas. Normal endometrial stromal cells express PR throughout the menstrual cycle, whereas stromal cells surrounding carcinomatous glands are PR negative in 70% cases. Therefore, abnormal expression of ER and/or PR in both glandular and stromal cells may be one of the characteristics of early neoplastic change of endometrial tumorigenesis. In normal endometrium, c- erbB-2 protein is expressed exclusively in glandular cells but EGFR is mainly associated with stromal cells. Most endometrial carcinomas exhibit the expression pattern of c-erbB-2 protein positive and EGFR negative, but advanced and/or poorly differentiated carcinomas express both c-erbB-2 protein and EGFR. This suggests that EGFR expression is associated with progression of endometrial carcinomas. Normal endometrial glands do not express p53, and only 16.5% cases of endometrial carcinomas express p53. p53-positive tumors tend to develop in older postmenopausal women, and show non-endometrioid histology without ER and PR expression. Therefore, p53 gene alteration may be associated with estrogen-unrelated carcinomas.
|
